<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230907059376N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-12-09</date_registration>
      <primary_sponsor>Afridi Medical Complex, Peshawar</primary_sponsor>
      <public_title>Comparison of transpedicular fixation with fusion with transpedicular fixation alone in spondylolisthesis: A Randomized Control Trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of Transpedicular fixation with fusion with transpedicular fixation alone in spondylolisthesis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-08-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>28</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74090</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients were grouped based on center and randomly assigned using a computer-generated permuted-block system. Allocations were kept in opaque, coded, and sealed envelopes by a data manager who was not engaged in the patient selection or allocation process. Following randomization, the prepared envelope was opened, the patient was told of the assigned intervention, and the necessary preparations were made for the assigned intervention, Blinding description: In the Randomized Controlled Trial (RCT), outcome assessors were blinded through a meticulous process where they were kept unaware of participants' assigned interventions. This ensured the assessments were conducted objectively, minimizing bias and enhancing the reliability of the trial's results.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Spondylolisthesis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants randomized to intervention group, undergoing Transpedicular Fixation with Fusion, will receive bilateral transpedicular fixation using pedicle screws, coupled with interbody fusion employing autograft or suitable bone substitute. This will be complemented by posterior stabilization using rods and cross-links. Intervention 2: Control group: Group B, designated for Transpedicular Fixation Alone, will involve bilateral transpedicular fixation with pedicle screws without interbody fusion, followed by posterior stabilization using rods and cross-links.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data will be available in the document under the title name, "Transpedicular fixation with fusion vs Transpedicular fixation alone in spondylolisthesis: A Randomized Control Trial"

When:
Data will be available after study is published for a year.

To whom:
Data will be available for researchers and neurosurgeons as well as neuro physicians.

Conditions:
Data will be used by giving credit to the Principal investigator, Dr. Muhammad Idris Khan consultant Neurosurgeon.

Where to obtain:
Documents will be provided through email to the Principal author Dr. Muhammad Idrees Khan (idrisnsw83@gmail.com)

How to obtain:
Documents will be provided through email to the Principal author Dr. Muhammad Idrees Khan (idrisnsw83@gmail.com)

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahboob Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Afridi medical complex tehkal payan, University Rd, Tehkal, Peshawar, Khyber Pakhtunkhwa</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25150</zip>
        <telephone>+92 91 5711751</telephone>
        <email>mehboob509@gmail.com</email>
        <affiliation>Afridi Medical Complex, Peshawar</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahboob Khan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Afridi medical complex tehkal payan, University Rd, Tehkal, Peshawar, Khyber Pakhtunkhwa</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25150</zip>
        <telephone>+92 91 5711751</telephone>
        <email>mehboob509@gmail.com</email>
        <affiliation>Afridi Medical Complex, Peshawar</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>First and second grade degenerative lumbar spondylolisthesis patients
Patients who would consent to participating in the study under ethical conditions
Both Gender Male and Female
Age 18-45 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Patients with additional lumbar spondylolisthesis types
Patients with additional lumbar degenerative spondylolisthesis grades (3rd and 4th grades)
Patients with additional spine pathology (lumbar fracture, disc prolapse)
Patients who respond to conservative treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M43.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Spondylolisthesis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants randomized to intervention group, undergoing Transpedicular Fixation with Fusion, will receive bilateral transpedicular fixation using pedicle screws, coupled with interbody fusion employing autograft or suitable bone substitute. This will be complemented by posterior stabilization using rods and cross-links.</i_keyword>
      <i_keyword>Control group: Group B, designated for Transpedicular Fixation Alone, will involve bilateral transpedicular fixation with pedicle screws without interbody fusion, followed by posterior stabilization using rods and cross-links.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Lumbar spine disability. Timepoint: Post-surgery for baseline and then after 6 and 12 months. Method of measurement: Oswestry Disability Index (ODI).</prim_outcome>
      <prim_outcome>Pain. Timepoint: Post-surgery for baseline and then after 6 and 12 months. Method of measurement: Visual analogue scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Afridi Medical Complex, Peshawar</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-07-09</approval_date>
        <contact_name>Afridi medical complex ethical commette</contact_name>
        <contact_address>Afridi medical complex tehkal payan, University Rd, Tehkal, Peshawar, Khyber Pakhtunkhwa 25150 Peshawar Khyber Pakhtunkhwa Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
